EDIT: We have decided to reconsider our approach, due to issues with off-target binding of afamelanotide that would likely complicate intranasal delivery. Apologies to all who have contacted us about our technology. We will turn our focus towards developing novel MC1R agonist molecules, and can still be reached at info@chromavel.com - please reach out if you are interested in our progress.
Last edited by Chromavel; 30th May 2016 at 01:24 AM.
Interesting! good luck
Please update when the Medstartr page will be added.
I would be interested in donating a good chunk of change, but do you have any contact information? I'd like to at least ask a few questions before throwing money at you guys.
Additionally, I am an author at Entrepreneur, Inc, Business.com, among many others, and would be able to help in other ways. But first, please contact me so I can ask a few questions!
Thanks!
EDIT: (Removed)
Last edited by Chromavel; 30th May 2016 at 01:24 AM.
EDIT: (Removed)
Last edited by Chromavel; 30th May 2016 at 01:24 AM.
Reply With Quote